Dr. Rahima Jamal’s research interests include clinical research, cancer immunotherapy, early clinical trials and melanoma.

Her research program focuses on the translation of basic research discoveries towards clinical research. In September 2018, she was appointed Medical Director of the Therapeutic Innovations Unit of the Centre hospitalier de l’Université de Montréal (CHUM), a unit dedicated to Phase I and II studies.